Detalhe da pesquisa
1.
Novel JAK Inhibitors to Reduce Graft-Versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation in a Preclinical Mouse Model.
Molecules
; 29(8)2024 Apr 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38675621
2.
Droplet and fibril formation of the functional amyloid Orb2.
J Biol Chem
; 297(1): 100804, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34044018
3.
Level of Attrition from Antiretroviral Therapy Among Human Immune Deficiency Virus-Infected Children: The Cases of Sidama Zone, Southern Ethiopia.
HIV AIDS (Auckl)
; 13: 813-822, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34413684
4.
Modeling Chronic Graft Versus Host Disease in Mice Using Allogeneic Bone Marrow and Splenocyte Transfer.
Curr Protoc Pharmacol
; 83(1): e47, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30204297
5.
Baricitinib-induced blockade of interferon gamma receptor and interleukin-6 receptor for the prevention and treatment of graft-versus-host disease.
Leukemia
; 32(11): 2483-2494, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29691471
6.
Baricitinib prevents GvHD by increasing Tregs via JAK3 and treats established GvHD by promoting intestinal tissue repair via EGFR.
Leukemia
; 36(1): 292-295, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34304247
7.
Targeting IFNGR/IL6R or downstream JAK1/JAK2 to control GvHD.
Oncotarget
; 9(87): 35721-35722, 2018 Nov 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30515263